Angiogenesis and anti-angiogenic therapy in prostate cancer.


Inhibition of angiogenic pathways has proven an effective strategy for the treatment of several common solid tumors however its role in the management of prostate cancer is yet to be defined. Advances in clinical research have resulted in five new treatments for metastatic prostate cancer in the last two years. The immunotherapy sipuleucel-T, the cytotoxic… (More)
DOI: 10.1016/j.critrevonc.2013.01.002


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics